Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients
Clinical trial NCT00193323 · COMPLETED
Trial details
- NCT number
- NCT00193323
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-08-01
- Primary completion
- 2006-05-01
- Enrollment
- 346
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.